Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-255-7 | CAS number: -
In a GLP and OECD guideline 406 study Daltolac XR 159 was evaluated in the Magnusson-Kligman guinea pig maximization model of delayed hypersensitivity. Prior to experimental initiation of the induction, the irritation potential of the test article was determined with a dose range-finding studies (intradermal and topical) utilizing 8 naïve guinea pigs. Based upon these results, the intradermal dose utilized was 5%, the topical induction dose was 100% and the challenge dose utilized was 100% in the main study.
The main study was conducted with 10 animals for the test article group and five animals for the vehicle control group.
No mortality was observed in any vehicle control or test article group animals in the study. No clinical signs were observed in any vehicle control group animals in the study. Decreased body tone was observed in one test article treated female on Day 21 through 25 of the study. No other clinical signs were noted in the test article treated group during the study.
Under the conditions of this study, an intradermal induction of Daltolac XR 159 at 5% with a topical induction at 100%, followed by a topical challenge at 100% to guinea pigs did elicit a dermal sensitization response at 24 and 48 hours post treatment. Therefore, Daltolac XR 159 is considered to be a contact sensitizer in Guinea Pigs.
Based on the results of the skin sensitizing test in Guinea pigs, Daltolac XR 159 is considered to be a contact sensitizer.
According to EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008, the classification is skin sen 1B, H317.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Close Do not show this message again